University of Western Australia
The Victor Chang Cardiac Research Institute and The University of Western Australia have signed a new strategic partnership that will significantly boost heart disease research in WA and across the country.
Victor Chang Cardiac Research Institute’s affiliation with UWA marks a new chapter for both organisations.
Professor Jason Kovacic, Executive Director of the Victor Chang Cardiac Research Institute, said the affiliation was the culmination of a long and proud history of working together.
“This is a proud day for the Institute and brings together the combined strengths of two world-leading organisations who are committed to tackling Australia’s biggest killer – heart disease,” said Professor Kovacic.
Image: Professor Livia Hool, Vice-Chancellor Professor Amit Chakma and Dr Lee Nedkoff.
“This also marks a major expansion for the Institute that will not only help the 100,000 Western Australians hospitalised by cardiovascular disease each year but will also improve the lives of people around the world.”
Cardiovascular disease is also responsible for 29 percent of deaths in WA.
UWA Vice-Chancellor Professor Amit Chakma said the University was pleased to partner with the Victor Chang Cardiac Research Institute to grow much-needed research capacity in Western Australia.
“This affiliation strengthens our commitment to addressing cardiovascular disease and creating a brighter future for Western Australians and the rest of the nation,” Professor Chakma said
As well as the affiliation, the Institute is also celebrating the opening of its second laboratory at UWA headed by Dr Lee Nedkoff.
Dr Nedkoff is a cardiovascular epidemiologist who is driving important research into coronary heart disease and stroke and is part of a team investigating rheumatic heart disease, which disproportionately affects Aboriginal and Torres Strait Islander peoples.
Dr Nedkoff joins the Institute’s Professor Livia Hool, who holds the Wesfarmers, UWA-VCCRI Chair in Cardiovascular Research, and has been running a collaborative research program at UWA since 2013. Professor Hool is working on a breakthrough preventative treatment for hypertrophic cardiomyopathy or enlarged heart syndrome.
Dr Nedkoff said: “This is a fantastic opportunity to help shape the future of heart disease research in Australia. The Institute’s reputation is second to none in driving new treatments and discoveries in the fight against heart disease.
“I am incredibly excited and honoured to join the team and bring a new set of skills to the Institute that I hope will shine a light on the true scale of cardiovascular disease in Western Australia, a state which has unique health challenges.”